| Cat. No. |
Product Name |
Information |
| PC-72697 |
MAP855
MEK1/2 inhibitor
|
MAP855 (MAP-855) is a highly potent, selective, ATP-competitive MEK1/2 inhibitor (pERK IC50=5 nM) with equipotent inhibition of WT and mutant MEK1/2. |
| PC-72696 |
DTP3
MKK7 inhibitor
|
DTP3 (MKK7 inhibitor DTP3) is a specific D-tripeptide that disrupts the GADD45β/MKK7 complex (Kd=64.8 nM), kills MM cells effectively, and lacks toxicity to normal cells. |
| PC-72695 |
MEK4 inhibitor 6ff
MEK4 inhibitor
|
MEK4 inhibitor 6ff is potent, selective MEK4 inhibitor with IC50 of 66 nM. |
| PC-72692 |
MEK4 inhibitor 15o
MEK4 inhibitor
|
MEK4 inhibitor 15o is potent, selective, cell permeable MEK4 inhibitor with IC50 of 83 nM. |
| PC-72689 |
MEK4 inhibitor 10e
MEK4 inhibitor
|
MEK4 inhibitor 10e is potent, selective cell permeable MEK4 inhibitor with IC50 of 61 nM. |
| PC-38277 |
BSJ-04-122
MKK4/7 inhibitor
|
BSJ-04-122 is a potent, selective, covalent dual MKK4/7 inhibitor with IC50 of 4/181 nM, displays excellent kinome selectivity. |
| PC-36064 |
MMK7 inhibitor 4a
MKK7 inhibitor
|
MMK7 inhibitor 4a is a potent, sepecific, covalent inhibitor of MMK7 with IC50 of 10 nM, displays >800-fold selectivity over EGFR-WT and EGFR-L858R/T790M. |
| PC-35805 |
MKK7-COV-9
MKK7 inhibitor
|
MKK7-COV-9 (MKK7 Covalen inhibitor 9) is a potent, selective, covalent MKK7 inhibitor, displays >1,000-fold selectivity over MKK4. |
| PC-35804 |
MKK7-COV-13
MKK7 inhibitor
|
MKK7-COV-13 (MKK7 Covalent inhibitor 13) is a potent, selective, covalent MKK7 inhibitor with in vitro IC50 of 10 nM, displays >1,000-fold selectivity over MKK4 (IC50>10 uM). |
| PC-35803 |
MKK7-COV-3
MKK7 inhibitor
|
MKK7-COV-3 (MKK7 Covalent inhibitor 3) is a potent, selective, covalent MKK7 inhibitor with in vitro IC50 of 5 nM, displays >1,000-fold selectivity over MKK4 (IC50=7.81 uM). |
| PC-43541 |
TAK-733
MEK inhibitor
|
TAK-733 (TAK733,TAK 733) is a potent, selective, allosteric inhibitor of MEK with IC50 of 3.2 nM (MEK1). |
| PC-43380 |
Cobimetinib R-enantiomer
|
Cobimetinib R-enantiomer (GDC-0973, XL518) is the R-enantiomer of Cobimetinib (GDC-0973, XL518), which is a potent, highly selective inhibitor of mitogen-activated protein kinase kinase(MEK1/2). |
